Lee-Jen Wei

14PUBLICATIONS
35CO-AUTHORS
Infectious diseasesCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersGene and molecular therapyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|May 12, 2026
Phase IIB, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Intravenous Defibrotide for the Prevention and Treatment of Respiratory Distress and Cytokine Release Syndrome in COVID-19.

|Mar 28, 2025
Assessing Clinical Utility of Datopotamab Deruxtecan Versus Chemotherapy for Breast Cancer.

Xuan Wang, Ethan B Ludmir, Lee-Jen Wei

|Dec 02, 2024
Pitfalls of Choosing a Study End Point Including Cardiovascular Death in Comparative Clinical Trials.

Stephanie Armbruster, Hicham Skali, Lee-Jen Wei

|Aug 08, 2024
Inferences for the distribution of the duration of response in a comparative clinical study.

Ying Cui, Bo Huang, Lu Mao

|Jun 04, 2024
Advancing Transthyretin Amyloidosis Drug Development in an Evolving Treatment Landscape: Amyloidosis Forum Meeting Proceedings.

Mathew S Maurer, Prem Soman, Adrian Hernandez

|Nov 21, 2023
Assessing Predictability of Pathologic Lymph Node Regression for Recurrence and Survival in Esophageal Adenocarcinoma.

Ryan Sun, Jingyi Liu, Lee-Jen Wei

Pageof 3

Frequent Collaborators

5 joint publications

Zachary R McCaw

2 joint publications

Lu Tian

2 joint publications

Hajime Uno

2 joint publications

Bo Huang